Last updated 2026-07-20
- Acquired by Menlo Therapeutics, Nov 2019
Total raised
—
Last: Undisclosed Round 2019-07
Stage
Public
Founded
2003
Headcount
47
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
VYNE Therapeutics is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions.
VYNE is working to develop and commercialize a variety of solutions using its proprietary Molecule Stabilizing Technology and has received FDA approval for AMZEEQ (minocycline) topical foam, 4%, a topical minocycline; and ZILXI (minocycline) topical foam, 1.5%, a minocycline product for the treatment of rosacea.
The company was formed from the merger of Foamix, an Israeli clinical-stage specialty pharmaceutical company, and Menlo Therapeutics, a US-based dermatology company.
Headcount over time
47 employees (2026-09) · 1 point
Offices
Ness Ziona, Israel · HQ / main office
Show all offices (1 more)
- Bridgewater Township, United States
Q&A
- What is VYNE Therapeutics' primary focus?
- VYNE Therapeutics is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions.
- Which products has VYNE Therapeutics received FDA approval for?
- VYNE Therapeutics has received FDA approval for AMZEEQ (minocycline) topical foam, 4%, a topical minocycline; and ZILXI (minocycline) topical foam, 1.5%, a minocycline product for the treatment of rosacea.
- When was VYNE Therapeutics formed and how?
- VYNE Therapeutics was formed in November 2019 from the merger of Foamix, an Israeli clinical-stage specialty pharmaceutical company, and Menlo Therapeutics, a US-based dermatology company.
- What was the last funding round for VYNE Therapeutics?
- VYNE Therapeutics' last funding round was in July 2019, raising $64,000,000 from investors including Perceptive Advisors and OrbiMed.
- What is the employee count for VYNE Therapeutics?
- VYNE Therapeutics has 51-200 employees.
- Who is the founder of Foamix Pharmaceuticals, which merged to form VYNE Therapeutics?
- Meir Eini is the Founder of Foamix Pharmaceuticals.
- What is the current status of VYNE Therapeutics?
- VYNE Therapeutics is currently listed as acquired and inactive, having been acquired by Menlo Therapeutics in November 2019.
- What is VYNE Therapeutics' total amount raised in funding?
- VYNE Therapeutics has raised a total of $180,000,000 USD.
Team · 10
David Domzalski
President, Chief Executive Officer and Director
Dr. Iain Stuart
Chief Scientific Officer
Mutya Harsch
General Counsel, Chief Legal Officer and Secretary
Tyler Zeronda
Chief Financial Officer, Principal Accounting Officer and Treasurer
Sharon Barbari
Board Member
Patrick G. LePore
Lead Independent Director
Anthony D Bruno
Independent Director
Dr. Christine Borowski
Independent Director
Steven L. Basta
Independent Director
Elisabeth A. Sandoval Little
Independent Director
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
skin-caredermatologytopical-treatmentacnepharmaceuticalstreatmentspharma-companiespatientsinflammatory-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | www.vynetherapeutics.com |
|---|---|
| linkedin.com/company/68042510 | |
| facebook.com/VYNEtx | |
| Wikidata | wikidata.org/wiki/Q104480752 |
Identifiers & details
| Legal name | VYNE Therapeutics Inc. |
|---|---|
| Former names | Foamix Pharmaceuticals, Menlo Therapeutics |
| Founded | 2003-1 |
| Employees (exact) | 47 |
| Offices | Bridgewater Township |
| Market cap | $19.3M |
| Status reason | Acquired (Inactive) by Menlo Therapeutics on Nov 2019 - ceased to operate |
| Wikidata QID | Q104480752 |
Acquisitions & public offerings
Acquired by Menlo Therapeutics 2019-11
Radar intelligence
Patents
| EPO | 16 |
|---|
Web history (Wayback)
| Domain | vynetherapeutics.com |
|---|
Wikidata
| QID | Q104480752 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513368811 |
|---|---|
| Status | מחוסלת מרצון — CLOSED |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2003-01-19 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2013 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | דרך בגין 52 תל אביב - יפו |